In SCA3/MJD, the delivery of the non-steroidal anti-inflammatory drug ibuprofen to human iPSC-derived neurons brought improvements to neuropathology markers of the disease, particularly the pro-inflammatory cytokines IL-1β and tumour necrosis factor alpha (TNFα) [354]. Here, IL1B is linked to Machado-Joseph disease.